About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: October 2010
TwitStrategy, Reach and Audience Impressions
For a long time there was, and to a great extent there still is, a chill over the use of the Internet and social media over the pharmaceutical industry. That is due to the fact that it is a highly … Continue reading
Posted in New and Social Media, Social Media
2 Comments
Public Meeting on Biosimilars Scheduled for November – Questions Posed by FDA
The FDA has finally scheduled a public meeting to solicit input on the regulatory pathway that is being developed for the approval of biosimilars. The meeting is set for November 2-3 and will be held at FDA's facility in Silver … Continue reading
Posted in Biologics
Comments Off on Public Meeting on Biosimilars Scheduled for November – Questions Posed by FDA
Weekly Roundup – 10/01/10
In nine days it will be 10/10/10 and then at 10:10:10 in the morning it will be 10/10/10.10.10.10 Just thought I'd point that out so you could anticipate it and look forward to it. October. Here in DC the leaves … Continue reading
Posted in Uncategorized
Comments Off on Weekly Roundup – 10/01/10